Air Products and Chemicals, Inc. (APD)

Basic

  • Market Cap

    $58.51B

  • EV

    $69.01B

  • Shares Out

    222.23M

  • Revenue

    $12.6B

  • Employees

    21,850

Margins

  • Gross

    29.9%

  • EBITDA

    31.83%

  • Operating

    21.05%

  • Pre-Tax

    22.88%

  • Net

    18.26%

  • FCF

    -11.27%

Returns (5Yr Avg)

  • ROA

    6.09%

  • ROE

    15.83%

  • ROCE

    10.94%

  • ROIC

    9.84%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $308.07

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $56.68

  • Earnings (Dil)

    $10.33

  • FCF

    -$6.38

  • Book Value

    $64.41

Growth (CAGR)

  • Rev 3Yr

    12.47%

  • Rev 5Yr

    7.13%

  • Rev 10Yr

    2.16%

  • Dil EPS 3Yr

    6.4%

  • Dil EPS 5Yr

    9.34%

  • Dil EPS 10Yr

    8.09%

  • Rev Fwd 2Yr

    7.94%

  • EBITDA Fwd 2Yr

    11.6%

  • EPS Fwd 2Yr

    11.15%

  • EPS LT Growth Est

    13.11%

Dividends

  • Yield

  • Payout

    66.61%

  • DPS

    $6.87

  • DPS Growth 3Yr

    9.87%

  • DPS Growth 5Yr

    10.08%

  • DPS Growth 10Yr

    9.51%

  • DPS Growth Fwd 2Yr

    7.2%

Select a metric from the list below to chart it

Sep '14
Sep '16
Sep '18
Sep '20
Sep '22

Total Revenues

8,918.9

8,856.3

10,323.0

12,698.6

12,600.0

Total Revenues % Chg.

-0.1%

-0.7%

16.6%

23.0%

-0.8%

Cost of Goods Sold, Total

5,975.5

5,858.1

7,186.1

9,338.5

8,833.0

Gross Profit

2,943.4

2,998.2

3,136.9

3,360.1

3,767.0

Selling General & Admin Expenses, Total

736.1

731.0

744.6

851.0

1,042.7

R&D Expenses

72.9

83.9

93.5

102.9

105.6

Other Operating Expenses

-49.3

-65.4

-52.8

-52.2

-33.8

Other Operating Expenses, Total

759.7

749.5

785.3

901.7

1,114.5

Operating Income

2,183.7

2,248.7

2,351.6

2,458.4

2,652.5

Interest Expense, Total

-137.0

-109.3

-141.8

-128.0

-177.5

Interest And Investment Income

Net Interest Expenses

-137.0

-109.3

-141.8

-128.0

-177.5

Income (Loss) On Equity Invest.

215.4

264.8

294.1

481.5

604.3

Currency Exchange Gains (Loss)

-203.7

65.5

Other Non Operating Income (Expenses)

53.6

-9.0

-8.3

226.4

-15.8

EBT, Excl. Unusual Items

2,315.7

2,395.2

2,495.6

2,834.6

3,129.0

Restructuring Charges

-54.5

33.8

-23.2

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

29.1

36.8

Gain (Loss) On Sale Of Assets

Asset Writedown

Other Unusual Items

-0.8

-5.2

-1.8

-79.9

-246.6

EBT, Incl. Unusual Items

2,289.5

2,423.8

2,507.4

2,754.7

2,882.4

Income Tax Expense

480.1

478.4

462.8

500.8

551.2

Earnings From Continuing Operations

1,809.4

1,945.4

2,044.6

2,253.9

2,331.2

Earnings Of Discontinued Operations

-14.3

70.3

12.6

7.4

Minority Interest

-49.4

-44.4

-15.8

-10.4

-38.4

Net Income

1,760.0

1,886.7

2,099.1

2,256.1

2,300.2

Net Income to Common Incl Extra Items

1,760.0

1,886.7

2,099.1

2,256.1

2,300.2

Net Income to Common Excl. Extra Items

1,760.0

1,901.0

2,028.8

2,243.5

2,292.8

Total Shares Outstanding

220.4

221.0

221.4

221.8

222.2

Weighted Avg. Shares Outstanding

220.3

221.2

221.6

222.0

222.3

Weighted Avg. Shares Outstanding Dil

221.6

222.3

222.5

222.5

222.7

EPS

8.0

8.5

9.5

10.2

10.3

EPS Diluted

7.9

8.5

9.4

10.1

10.3

EBITDA

3,266.5

3,433.7

3,672.9

3,796.6

4,010.8